Iht Wealth Management, LLC Genprex, Inc. Transaction History

Iht Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.19 - $0.37 $190 - $370	1,000 Added 1.21%	83,372 $19,000
Q1 2023 May 15, 2023	BUY	$0.76 - $1.78 $22,797 - $53,394	29,997 Added 57.27%	82,372 $74,000
Q3 2021 Nov 15, 2021	BUY	$2.59 - $3.36 $51,800 - $67,200	20,000 Added 61.78%	52,375 $140,000
Q1 2021 May 18, 2021	BUY	$3.66 - $7.67 $10,943 - $22,933	2,990 Added 10.18%	32,375 $140,000
Q4 2020 Feb 17, 2021	SELL	$3.03 - $5.51 $36,360 - $66,120	-12,000 Reduced 29.0%	29,385 $122,000
Q1 2020 May 13, 2020	BUY	$0.28 - $6.23 $11,587 - $257,828	41,385 New	41,385 $100,000
Q4 2019 Feb 18, 2020	SELL	$0.24 - $0.75 $4,650 - $14,531	-19,375 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$1.2 - $1.85 $23,250 - $35,843	19,375 New	19,375 $24,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.